{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:45:37Z","timestamp":1769503537540,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgme.2023.107633","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T05:34:05Z","timestamp":1687671245000},"page":"107633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening"],"prefix":"10.1016","volume":"140","author":[{"given":"Nishitha R.","family":"Pillai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle Andrea V.","family":"Fabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tory V.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondra D.","family":"Rosendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy D.","family":"Hietala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa B.","family":"Jorgenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan C.","family":"Lanpher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2023.107633_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.gim.0000204462.42910.b8","article-title":"Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome","volume":"8","author":"Howell","year":"2006","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107633_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107633_bb0015","first-page":"S28","article-title":"75. Clinical signs and symptoms of Pompe disease in 120 infantile-onset and 373 late-onset patients: a report from the Pompe registry","volume":"96","author":"Kishnani","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107633_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2021.12.072","article-title":"Outcome of later-onset Pompe disease identified through newborn screening","volume":"244","author":"Lee","year":"2022","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107633_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2022.01.003","article-title":"Early clinical phenotype of late onset Pompe disease: lessons learned from newborn screening","volume":"135","author":"Huggins","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107633_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107633_bb0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107633_bb0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J. Neurol."},{"issue":"13","key":"10.1016\/j.ymgme.2023.107633_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.21037\/atm.2019.04.15","article-title":"Challenges in treating Pompe disease: an industry perspective","volume":"7","author":"Do","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107633_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6020048","article-title":"Expanding newborn screening for Pompe disease in the United States: the NewSTEPs new disorders implementation project, a resource for new disorder implementation","volume":"6","author":"Hale","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107633_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns4010001","article-title":"NewSTEPs: the establishment of a National Newborn Screening Technical Assistance Resource Center","volume":"4","author":"Ojodu","year":"2018","journal-title":"Int. J. Neonatal. Screen."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107633_bb0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107633_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/gim.2017.190","article-title":"Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease","volume":"20","author":"Tortorelli","year":"2018","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107633_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107633_bb0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107633_bb0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.22108","article-title":"Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants","volume":"33","author":"Kroos","year":"2012","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107633_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s43042-021-00203-7","article-title":"Molecular study of Pompe disease in Egyptian infants","volume":"22","author":"Essawi","year":"2021","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107633_bb0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","article-title":"Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years","volume":"259","author":"Angelini","year":"2012","journal-title":"J. Neurol."},{"issue":"D1","key":"10.1016\/j.ymgme.2023.107633_bb0105","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107633_bb0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41436-019-0738-0","article-title":"Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature","volume":"22","author":"Khan","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107633_bb0115","article-title":"Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: evidence from real-world experiences","volume":"23","author":"Chien","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107633_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010011","article-title":"Lessons learned from Pompe disease newborn screening and follow-up","volume":"6","author":"Klug","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107633_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijns6010004","article-title":"Newborn screening for Pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107633_bb0130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107633_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijns4030023","article-title":"Newborn screening for lysosomal storage diseases: methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools","volume":"4","author":"Gelb","year":"2018","journal-title":"Int. J. Neonatal. Screen."},{"issue":"Supplement 1","key":"10.1016\/j.ymgme.2023.107633_bb0140","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to a confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107633_bb0145","first-page":"24","article-title":"Hypothyroidism in late-onset Pompe disease","volume":"8","author":"Schneider","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107633_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11154-016-9357-0","article-title":"Hypothyroid myopathy: a peculiar clinical presentation of thyroid failure. Review of the literature","volume":"17","author":"Sindoni","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ymgme.2023.107633_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-7-88","article-title":"Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study","volume":"7","author":"van der Beek","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107633_bb0160","first-page":"921","article-title":"The endocrine glands in Pompe\u2019s disease. Report of two cases","volume":"109","author":"Hui","year":"1985","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"7637","key":"10.1016\/j.ymgme.2023.107633_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(70)91849-0","article-title":"Reduced muscle alpha-glucosidase (acid-maltase) activity in hypothyroid myopathy","volume":"1","author":"Hurwitz","year":"1970","journal-title":"Lancet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:07Z","timestamp":1761090847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1096719223002639"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107633","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107633"}}